Internal Server Error

OneSource - About the company

OneSource is a public company based in Bengaluru (India), founded in 1990 by Natalie Shaba. It operates as a Pharmaceutical contract development and manufacturing organization offering pharmaceutical products. OneSource has raised $155M in funding from investors like Erasmic Venture Fund, Accel and TPG. The company has 292 active competitors, including 21 funded and 19 that have exited. Its top competitors include companies like Suanfarma, Nephron Pharmaceuticals and Quotient Sciences.

Company Details

Pharmaceutical contract development and manufacturing organization offering pharmaceutical products. It specializing in biologics, drug-device combinations, soft gelatin capsules, and sterile injectables. It offers end-to-end capabilities for pharmaceutical companies. The company's broad capabilities enable it to support clients throughout the product development lifecycle, from development to commercialization.
Registered Address
Unit No. 902, Cyber One, Plot No - 4 & 6, Sector 30A, Vashi, Navi Mumbai, Sanpada, Thane, Thane, Maharashtra, India, 400703
Key Metrics
Founded Year
1990
Location
Bengaluru, India
Stage
Public
Total Funding
$155M in 7 rounds
Latest Funding Round
Ranked
Annual Revenue
₹1,000+ Cr as on Mar 31, 2026
Employee Count
567 as on Nov 30, 2024
Similar Companies
Exit Details
Public

OneSource's IPO details

OneSource got listed on Jan 24, 2025.
Click here to take a look at OneSource's IPO in detail
Sign up to download OneSource's company profile

OneSource's funding and investors

OneSource has raised a total funding of $155M over 7 rounds. Its first funding round was on Dec 22, 2007. Its latest funding round was a Series C round on Mar 19, 2021 for $*****. 7 investors participated in its latest round. OneSource has 13 institutional investors and 4 angel investors.

Here is the list of recent funding rounds of OneSource:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Mar 19, 2021
8657820
Series C
5450054
4921195
7191905
8285749
Nov 26, 2018
9171949
Series B
4794109
7412036
3007537
Feb 23, 2016
5176998
Series B
5901163
8882264
lockAccess funding benchmarks and valuations. Sign up today!

OneSource's founders and board of directors

Founder? Claim Profile
The founders of OneSource is Natalie Shaba. Natalie Shaba and Neeraj Sharma are the CEOs of OneSource.
Here are the details of OneSource's key team members:

OneSource's Board of Directors

OneSource's board has 8 active members. Neeraj Sharma is part of team and Bharat Dhirajlal Shah, Bhushan Sudhir Bopardikar, Gopakumar Gopalan Nair, Arun Kumar Pillai, Rajashri Santosh Kumar Ojha, Rashmi Harshadrai Barbhaiya and Mahadevan Narayanamoni are independent board members.
Here is the list of OneSource's board of directors:
Name
Type
Representing
Status
Duration
cesanjo
Team
-
Current
7y 1m
Independent board member
-
Current
2y 2m
gkiejkr
Independent board member
-
Current
3y 1m
qdngina
Independent board member
-
Current
7y 7m
uqotnlk
Independent board member
-
Current
4y 2m
aucrwem
Independent board member
-
Current
4y 4m
pqbiykm
Independent board member
-
Current
6y 4m
tqjmvag
Independent board member
-
Current
3y 4m

OneSource's employee count trend

OneSource has 567 employees as of Nov 24. The total employee count is 9.0% more than what it was in Nov 23. Here is OneSource's employee count trend over the years:
Employee count trend for OneSource
lockUncover OneSource's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

OneSource's Competitors and alternates

Top competitors of OneSource include Suanfarma, Nephron Pharmaceuticals and Quotient Sciences. Here is the list of Top 10 competitors of OneSource, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Suanfarma
Suanfarma
1993, Madrid (Spain), Acquired
Developer of generics, nutraceuticals, and APIs
-
60/100
2nd
Logo for Nephron Pharmaceuticals
Nephron Pharmaceuticals
1937, Florida (Puerto Rico), Late Stage
Manufacturer of sterile pharmaceutical products and provider of contract manufacturing and 503B outsourcing services
$625M
58/100
3rd
Logo for OneSource
OneSource
1990, Bengaluru (India), Public
Pharmaceutical contract development and manufacturing organization offering pharmaceutical products
$155M
57/100
4th
Logo for Quotient Sciences
Quotient Sciences
1990, Nottingham (United Kingdom), Acquired
Developer and manufacturer of APIs as well as finished dosage forms
-
55/100
5th
Logo for Wheeler Bio
Wheeler Bio
2020, Oklahoma City (United States), Series A
Provider of drug research and analytical development services for multiple therapeutic areas
$103M
53/100
6th
Logo for LSL Pharma Group
LSL Pharma Group
2023, Boucherville (Canada), Public
Integrated pharmaceutical company provides pharma products
-
-
47/100
7th
Logo for Aiolos Bio
Aiolos Bio
2023, Boston (United States), Acquired
Biotech company focused on developing innovative therapies for respiratory diseases and immune conditions
$245M
47/100
8th
Logo for LYOCONTRACT
LYOCONTRACT
2007, Ilsenburg (Germany), Acquired
Provider of a pharmaceutical manufacturing site with capabilities for producing liquid and freeze-dried parenteral drugs in vials
-
45/100
9th
Logo for Antibiotice
Antibiotice
1955, Iasi (Romania), Funding Raised
Manufacturer of human and veterinary medicines, active substances, and medical devices
-
45/100
10th
Logo for Althea Technologies
Althea Technologies
1998, San Diego (United States), Acquired
Contract-based manufacturer and distributor of clinical drugs and vaccines
$23M
44/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on OneSource's competitors? Click here to see the top ones

OneSource's Latest cap tables and shareholding

Funds own 19.68%, Parent Entities own 36.69%, Enterprises (largest shareholder) own 38.73% and Angels own 3.70%. The cap table displayed below is for ONESOURCE SPECIALTY PHARMA LIMITED which is the legal entity associated with OneSource.
Shareholders Name
Post Round Holding %
Net worth
Cumulative Investment
Realised Returns
Unrealised Returns
Return Multiple
Fund
19.68%
388Cr
6401172
9458075
3203536
2015730
59443
64088
52678
93281
34038
56813
0
0
0
0
0
0
Parent Entity
36.69%
724Cr
6273229
6983310
1926617
1463176
Enterprise
38.73%
764Cr
6856077
5295338
3775165
8563103
Angel
3.70%
73Cr
468
479
384
214
0
0
0
0
0
0
Other People
0.12%
2.35Cr
0
0
0
0
ESOP Pool
1.08%
21.3Cr
4
8
1
6
Total
100.00%
1,970Cr
2228695
6827607
2244734
7522084
Notes: The column Net Worth represents the net worth of investments made by that entity, as per the latest cap table.
Disclaimer
Gain deeper insights into
shareholding pattern of this entity
$9.99$4.23(excl. taxes)
Download Sample Files
What documents will you get?
  • Latest Shareholding Summary - Ownership breakdown across founders, investors, and other stakeholders
  • Round-by-Round Cap Tables - Evolution of shareholding across funding rounds
  • Year-on-Year Cap Tables - Dilution trends over time

OneSource's Investments and acquisitions

OneSource has made no investments or acquisitions yet.

Reports related to OneSource

Here is the latest report on OneSource's sector:

News related to OneSource

lockFilter this list
Media has covered OneSource for a total of 8 events in the last 1 year, 1 of them has been about company updates and 1 about partnerships.
•
OneSource Specialty posts Rs 44.9 crore net profitMoneycontrol•Nov 12, 2025•OneSource
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about OneSource

Explore our recently published companies
  • Musitech - Unfunded company
  • Kind AI - 2025 founded, Funding Raised company
  • Kirik - Bengaluru based, 2024 founded, Unfunded company
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford